SEC Form 4 · accession 0001387131-17-005914
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John K Bakewell
Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 8:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 15, 2017 | A | 32,072 | A | — | — | Common Stock | 32,072 | 32,072 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.0001 per share, of Corindus Vascular Robotics, Inc.
- F2The restricted stock units were granted on December 15, 2017 as part of the director's annual equity award with vesting beginning as of August 8, 2017, the date of the reporting person's appointment as a director. The restricted stock units vest in four equal quarterly installments on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. Vested shares will be delivered to the reporting person within five days of each such vesting date.